The biotech sector is set for strong growth thanks to ongoing innovations like gene editing and tissue engineering and the use of machine learning, and big data analytics tools. With a growing demand for advanced healthcare solutions, innovative vaccines, and therapies, coupled with investments in R&D, an aging population, and government initiatives, the industry looks well-positioned for expansion.
Amid this backdrop, investors could consider adding fundamentally strong biotech stocks Innoviva, Inc. (INVA), Halozyme Therapeutics, Inc. (HALO), Jazz Pharmaceuticals plc (JAZZ), and Entrada Therapeutics, Inc. (TRDA).
